pemetrexed,cisplatin,gemcitabine,pembrolizumab
merck
['keynote,671', 'nsclc', 'keynote 671', 'sclc']
great presentation and discussion of keynote 671 by and at #asco23 another evidence in support of neoadjuvant chemo-io for patients with resectable nsclc (stage ii-iiib ajcc 8). efs curves suggest possible contribution of adjuvant io to long term outcomes
Thoracic Medical Oncologist at Karmanos Cancer Institute